Press Contact Information:
February 28, 2018, Ann Arbor, Michigan. AlertWatch, an Ann Arbor—based digital health firm, today announced a major strategic relationship with Qualcomm life. Through the relationship, Qualcomm Life made a seven figure financial investment in AlertWatch and obtained the exclusive, world-wide rights to market the AlertWatch:OR product.
AlertWatch supports anesthesia providers by displaying a high-level dashboard view of the patient and alerting for certain quality and safety issues in real time so the care of each patient can be improved. The software integrates, analyzes, and displays hundreds of data points in a single, intuitive display of the human body.
“AlertWatch and Qualcomm Life (QCL) are a natural fit. In addition to having their chips powering billions of devices worldwide, their Capsule & 2net platform are in over 2,000 hospitals across the world, helping to bring forward the next generation of intelligent healthcare solutions. By seamlessly integrating our solutions onto their platforms, we can bring real-time monitoring & alerting solutions to anesthesia providers worldwide,” said Justin Adams, CEO of AlertWatch.
AlertWatch has over 100 proprietary algorithms, automated calculations, and alerts that can help providers quickly assess clinical situations without having to pore through dozens of electronic medical record (EMR) screens and tabs. The system integrates with all major EMR systems, and, of course, all major QCL technologies.
“The timing couldn’t be better. We’re expected to grow our revenue 4x in 2018 compared to 2017, and we’re already hiring additional team members to help us grow while continuing to provide best-in-class support to our hospital customers. And we’re carefully expanding our platform into the labor & delivery unit, as well as the ICU, and other wired locations throughout the hospital. The team at QCL has provided invaluable guidance as we expand what we’ve started,” added Justin.
This strategic relationship comes on the heels of a 6-year study published in the February 2018 issue Journal Anesthesiology. “That study showed that patients, when operated on with AlertWatch:OR providing support, had improved intraoperative care measures. More importantly, AlertWatch monitored patients went home a day earlier when compared to those who were not monitored by the system. This was not only great for the patient, but the hospital also saw charges go down $3,603 per case for these higher risk patients,” said Dr. Kevin Tremper, Chair of Anesthesiology at the University of Michigan, and the founder of AlertWatch.
Dr. James Mault, Senior VP & Chief Medical Officer of QCL, and a graduate of the University of Michigan for both his undergraduate and medical degrees, made a dozen “homecoming” trips to Ann Arbor while doing due diligence on AlertWatch. “Some of my best memories are from my time in Ann Arbor. What Kevin and the AlertWatch team have done is incredible. They’ve commercialized the first patient-specific integrated monitoring solution for the perioperative continuum of care. We’ll be work diligently with them to expand their predictive analytics and installation footprint over the coming years.”
For more information and to see a demo of the AlertWatch platform, visit www.alertwatch.com.
AlertWatch, Inc. produces real-time patient monitoring software focused on improving quality and safety. Their first solution, AlertWatch:OR, received FDA clearance in 2014. AlertWatch:OR is focused on improving intraoperative care to help reduce postoperative complications. AlertWatch:OB, a solution for monitoring mothers in the labor & delivery ward, is focused on reducing maternal mortality. AlertWatch:OB is pending FDA clearance. For more information, visit www.alertwatch.com, or email email@example.com.
Qualcomm’s technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries, including automotive, computing, IoT, healthcare and data center, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including, our QCT semiconductor business.